Mirum Pharmaceuticals (MIRM) Operating Income (2020 - 2025)
Historic Operating Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $2.6 million.
- Mirum Pharmaceuticals' Operating Income rose 12052.19% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.8 million, marking a year-over-year increase of 5645.36%. This contributed to the annual value of -$87.6 million for FY2024, which is 1974.09% up from last year.
- Per Mirum Pharmaceuticals' latest filing, its Operating Income stood at $2.6 million for Q3 2025, which was up 12052.19% from -$5.0 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Operating Income ranged from a high of $2.6 million in Q3 2025 and a low of -$47.6 million during Q1 2021
- In the last 5 years, Mirum Pharmaceuticals' Operating Income had a median value of -$27.1 million in 2023 and averaged -$27.3 million.
- Its Operating Income has fluctuated over the past 5 years, first plummeted by 11610.84% in 2021, then soared by 12052.19% in 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Operating Income (Quarter) stood at -$45.6 million in 2021, then grew by 25.04% to -$34.2 million in 2022, then rose by 4.61% to -$32.6 million in 2023, then grew by 25.67% to -$24.2 million in 2024, then soared by 110.75% to $2.6 million in 2025.
- Its last three reported values are $2.6 million in Q3 2025, -$5.0 million for Q2 2025, and -$15.2 million during Q1 2025.